CIK: 1753193 - Address: Rungsted Strandvej 113, Rungsted Kyst, G7 2960
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/12/23 08:27
12/11/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DP446.850604,559D
12/11/23 17:25
12/7/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DP.m8906.98012834,553D
12/1/23 17:15
11/29/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DP3095.9705214,425D
11/29/23 17:14
11/27/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DP.m5215.5909324,373D
5/17/23 17:05
5/15/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DHSee RemaP9819.65010224,280D
6/11/21 17:01
6/10/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DHSee RemaS-40636.150-1104,178D
6/10/21 19:00
6/8/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7DHSee RemaS.m-5,39835.990-150-34,190D
6/9/21 18:51
6/7/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7TS-2,47334.150-72-24,340D
6/7/21 16:30
6/3/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7TS.m-1,14833.280-35-14,412D
6/2/21 16:31
5/28/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWg Biotech ApsG7TS.m-1,15336.170-32-14,447D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact